Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Opioid Use Disorder
Clinical trial register · United States · industry-sponsored

Opioid Use Disorder Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9144 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 16 Oct 2026, 03:16 UTC
9144
Studies in scope
industry-sponsored, all four open statuses
4957
Recruiting now
open to new participants
2196
Lead sponsors
across recruiting studies
Top states
California 3 Indiana 3 Florida 2 Illinois 2 Maryland 2
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Opioid Use Disorder trials in the USA

12 of 9144 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
NCT07871877Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders
Clive Michelsen
Phase 1/2
60
Colorado
2027-07-01
Active, closed
Akyso Therapeutics, LLC
Phase 1
33
Utah
2026-07-25
Recruiting
Eli Lilly and Company
Phase 2
465
Arizona, Arkansas, California, Florida, Illinois, Indiana, Kentucky, Maryland
2026-02-13
Recruiting
Boulder Care
Phase 1
250
Oregon
2025-06-10
Recruiting
Spark Biomedical, Inc.
Observational
20
Minnesota, Ohio
2025-02-19
Recruiting
Brain Training for Substance Use Disorders
NCT06870110Opioid Use Disorder
Neurotype Inc.
Not applicable
40
Minnesota
2025-01-17
Recruiting
Remotely Observed Methadone Evaluation II
NCT06338280Opioid Use Disorder
Sonara Health
Phase 2
100
Illinois
2024-12-24
Recruiting
AvertD Post-Approval Study
NCT07135323Opioid Use Disorder
Prescient Medicine Holdings, Inc.
Observational
4,000
Indiana
2024-11-15
Recruiting
Proniras Corporation
Phase 1
40
Indiana
2024-10-16
Active, closed
BehaVR LLC
Not applicable
128
California, Utah
2023-09-07
Active, closed
Pilot Research on Opioid Use Disorder
NCT04244227Opioid-use Disorder
Theranova, L.L.C.
Not applicable
10
California
2020-03-10
Recruiting
InSightec
Not applicable
29
Florida, Maryland, New York, West Virginia
2019-11-27
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/opioid-use-disorder

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,144 studies in total at the last sync on 16 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Opioid Use Disorder.

How many Opioid Use Disorder trials are recruiting in the US?

8 of the 12 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Opioid Use Disorder), 12 studies
PhaseStudiesRecruitingShare
Not applicable4233.3%
Phase 13225%
Observational2216.7%
Phase 22216.7%
Phase 1/2108.3%

Most active sponsors

Lead sponsors with the most studies (Opioid Use Disorder)
Lead sponsorStudiesRecruiting
Akyso Therapeutics, LLC10
BehaVR LLC10
Boulder Care11
Clive Michelsen10
Eli Lilly and Company11
InSightec11
Neurotype Inc.11
Prescient Medicine Holdings, Inc.11
Proniras Corporation11
Sonara Health11

Top states

Top states (Opioid Use Disorder), by number of studies with a site there
StateStudies
California3
Indiana3
Florida2
Illinois2
Maryland2
Minnesota2
Utah2
Arizona1
Arkansas1
Colorado1
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.